These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1661638)

  • 21. [Magnetic resonance in the evaluation of breast pathology].
    Gualdi GF; Ballesio L; Caterino M; Trasimeni G; Pirolli FM; Melone AK
    Clin Ter; 1988 Sep; 126(5):363-7. PubMed ID: 2973966
    [No Abstract]   [Full Text] [Related]  

  • 22. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging.
    Jacobs MA; Barker PB; Bluemke DA; Maranto C; Arnold C; Herskovits EH; Bhujwalla Z
    Radiology; 2003 Oct; 229(1):225-32. PubMed ID: 14519877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytohistopathological correlations on material obtained by needle biopsy of the breast].
    Olivieri A; Aimone V; Parisio F; Ghiringhello B
    Minerva Ginecol; 1981 Apr; 33(4):345-50. PubMed ID: 6264357
    [No Abstract]   [Full Text] [Related]  

  • 24. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
    Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound visualization of the breast in symptomatic patients.
    Harper P; Kelly-Fry E
    Radiology; 1980 Nov; 137(2):465-9. PubMed ID: 6254111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of early diagnosis in the improvement of prognosis in breast carcinoma: non-palpable lesions. Preliminary results].
    Latteri M; Cipolla C; Amato C; Bottino A; Graceffa G; Cassano T; Salanitro L; Bajardi G; Tomasino RM; Nuara R
    Minerva Chir; 1990 Dec; 45(23-24):1439-45. PubMed ID: 1965017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and radiographic methods in the diagnosis of breast neoplasms].
    Gniewosz Z
    Wiad Lek; 1971 Dec; 24(23):2201-8. PubMed ID: 4334393
    [No Abstract]   [Full Text] [Related]  

  • 28. Magnetic resonance imaging in the diagnosis of breast disease.
    Dash N; Lupetin AR; Daffner RH; Deeb ZL; Sefczek RJ; Schapiro RL
    AJR Am J Roentgenol; 1986 Jan; 146(1):119-25. PubMed ID: 3484399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroadenomas: histopathologic and MR imaging features.
    Stelling CB; Powell DE; Mattingly SS
    Radiology; 1987 Feb; 162(2):399-407. PubMed ID: 3797653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA distribution pattern and comparison of quantitative data in breast tumours.
    Megyesi J; Udvarhelyi N; Sugár J; Molnár B; Delides GS
    Arch Geschwulstforsch; 1990; 60(3):217-22. PubMed ID: 2164368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrast-enhanced magnetic resonance imaging of the breast.
    Gribbestad IS; Nilsen G; Fjøsne H; Fougner R; Haugen OA; Petersen SB; Rinck PA; Kvinnsland S
    Acta Oncol; 1992; 31(8):833-42. PubMed ID: 1337832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a known breast cancer using an abbreviated breast MRI protocol: Correlation of imaging characteristics and pathology with lesion detection and conspicuity.
    Heacock L; Melsaether AN; Heller SL; Gao Y; Pysarenko KM; Babb JS; Kim SG; Moy L
    Eur J Radiol; 2016 Apr; 85(4):815-23. PubMed ID: 26971429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
    Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
    Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary of carcinoma of the breast in ceylonese using enzyme histochemical techniques: (demonstration of alkaline phosphatase: an aid to diagnosis?).
    Panabokke RG
    Ceylon Med J; 1978 Dec; 23(4):111-9. PubMed ID: 554736
    [No Abstract]   [Full Text] [Related]  

  • 35. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI?
    Kuhl CK; Klaschik S; Mielcarek P; Gieseke J; Wardelmann E; Schild HH
    J Magn Reson Imaging; 1999 Feb; 9(2):187-96. PubMed ID: 10077012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI.
    Flickinger FW; Allison JD; Sherry RM; Wright JC
    Magn Reson Imaging; 1993; 11(5):617-20. PubMed ID: 8345775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign breast disease.
    McGregor PE; Snyder TE
    Kans Med; 1991 Apr; 92(4):101-8. PubMed ID: 1881020
    [No Abstract]   [Full Text] [Related]  

  • 38. [Nuclear magnetic resonance tomography of the breast: diagnosis, differential diagnosis, problems and possible solutions. II: Diagnosis].
    Kaiser W; Zeitler E
    Rofo; 1986 May; 144(5):572-9. PubMed ID: 3012684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytologic study of punctates in mammary gland diagnosis].
    Zajicek J
    Schweiz Med Wochenschr; 1969 Sep; 99(36):1271-3. PubMed ID: 4310851
    [No Abstract]   [Full Text] [Related]  

  • 40. Ultrasonic detection of breast cancer.
    Kobayashi T
    Clin Obstet Gynecol; 1982 Jun; 25(2):409-23. PubMed ID: 6286200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.